IDEXX Laboratories Aktie

IDEXX Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 888210 / ISIN: US45168D1046

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
04.05.2018 12:50:44

IDEXX Labs Boosts 2018 EPS Outlook, But Backs Revenue View - Quick Facts

(RTTNews) - IDEXX Laboratories, Inc. (IDXX) on Friday raised its earnings outlook for the full-year 2018 by $0.02 to a range of $4.06 to $4.20 per share, as operational upsides are offset by impacts from updated foreign exchange rate outlook.

However, the company continues to expect 2018 revenue guidance in the range of $2.205 billion to $2.245 billion, reflecting reported growth of 12 to 14 percent, but raised 2018 organic revenue growth guidance by 1 percent to 10.5 to 12.5 percent, which is offset by change in foreign exchange rate outlook.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.12 per share on revenue growth of 12.9 percent to $2.22 billion for the year. Analysts' estimates typically exclude special items.

For 2018, the company also projects capital spending of about $140 million.

Analysen zu IDEXX Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEXX Laboratories 344,60 -4,36% IDEXX Laboratories